About the Company
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CYTK News
Cytokinetics gets grant for pharmaceutical compounds for medical use
Discover the groundbreaking patent granted to Cytokinetics Inc for compounds of Formula (I) with therapeutic potential for heart diseases. Learn about Compound 4 and Compound 18 and their applications ...
Cytokinetics Inc (CYTK) Volatility Hits 3.64%: How An Investor Should Respond
Having a second look at Cytokinetics Inc (NASDAQ:CYTK) provides that stock’s average daily trading volume for 3 months was 2.29 million, while it jumped to 1.02 million when we calculate an average ...
Is Now An Ideal Time To Purchase Cytokinetics Inc (NASDAQ: CYTK) Stock?
Cytokinetics Inc (NASDAQ:CYTK) traded at $72.71 at close of the session on Friday, April 05, made an upward move of 5.10% on its previous day’s price.
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
GLP-1 medications will likely expand beyond their current uses for diabetes or weight loss, according to money managers at ...
Why an ALS Drug Was Pulled From the Market
DENVER -- Topline data presented here showed why Amylyx Pharmaceuticals decided to remove its amyotrophic lateral sclerosis ...
Buy Rating Affirmed for MacroGenics on Strong Oncology Pipeline and Positive Phase II Trial Results
Mayank Mamtani, an analyst from B.Riley Financial, has initiated a new Buy rating on MacroGenics (MGNX). Mayank Mamtani has given his Buy ...
Event-Data Protection: New Scenarios to Consider
If proprietary research or confidential data is leaked from a life-sciences meeting, there can be serious competitive or ...
Truist Financial Reaffirms Their Buy Rating on Biogen (BIIB)
Devarakonda covers the Healthcare sector, focusing on stocks such as Cytokinetics, Keros Therapeutics ... Massachusetts-based Biogen, Inc. is a biopharmaceutical company, which discovers, develops, ...
Capri falls amid reports that FTC preparing to block $8.5B Tapestry deal (update)
Capri Holdings drops nearly 5% as the Federal Trade Commission considers suing to block its sale to Tapestry, with a meeting scheduled for this week.
Wegovy Helps HFpEF Patients With Diabetes Mellitus
A TLANTA -- Weight loss and heart failure benefits with semaglutide (Wegovy) extended to patients with obesity-related heart ...
DelveInsight Business Research, LLP: Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding elderly population susceptible to ...
Loading the latest forecasts...